Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells
Open Access
- 10 March 2020
- Vol. 12 (3), 640
- https://doi.org/10.3390/cancers12030640
Abstract
Pancreatic duct cells are equipped with acid/base transporters important for exocrine secretion. Pancreatic ductal adenocarcinoma (PDAC) cells may utilize such transporters to acidify extracellular tumor microenvironment, creating a niche favoring cell proliferation, fibrosis and resistance to chemotherapy—all contributing to the notoriously bad prognosis of this disease. Here, we report that gastric and non-gastric H+, K+-ATPases (coded by ATP4A and ATP12A) are overexpressed in human and murine pancreatic cancer and that we can target them specifically with proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) in in vitro models of PDAC. Focusing on pantoprazole, we show that it significantly reduced human cancer cell proliferation by inhibiting cellular H+ extrusion, increasing K+ conductance and promoting cyclin D1-dependent cell cycle arrest and preventing STAT3 activation. Pantoprazole also decreased collagen secretion from pancreatic stellate cells. Importantly, in vivo studies show that pantoprazole treatment of tumor-bearing mice reduced tumor size, fibrosis and expression of angiogenic markers. This work provides the first evidence that H+, K+-ATPases contribute to PDAC progression and that these can be targeted by inhibitors of these pumps, thus proving a promising therapeutic strategy.Funding Information
- Novo Nordisk Fonden (1072301001)
- Lundbeckfonden (R173-2014-1462)
This publication has 59 references indexed in Scilit:
- Disrupting proton dynamics and energy metabolism for cancer therapyNature Reviews Cancer, 2013
- Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho-LRP6 expression in Wnt/β-catenin signalingOncology Reports, 2013
- Acidic extracellular microenvironment and cancerCancer Cell International, 2013
- The Pancreas Cancer MicroenvironmentClinical Cancer Research, 2012
- Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control studyBritish Journal of Cancer, 2011
- The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancerLaboratory Investigation, 2011
- Pancreatic Bicarbonate Secretion Involves Two Proton PumpsOnline Journal of Public Health Informatics, 2011
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous MetastasesCancer Research, 2009
- The gastric HK-ATPase: structure, function, and inhibitionPflügers Archiv - European Journal of Physiology, 2008
- Proton Pump Inhibitors Induce Apoptosis of Human B-Cell Tumors through a Caspase-Independent Mechanism Involving Reactive Oxygen SpeciesCancer Research, 2007